Acute respiratory distress syndrome

4 trials 3 recruiting MedDRA PT
4 Registered trials
3 Recruiting
4 Unique sponsors
3 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
L Oncology (ATC L) 1
A Gastroenterology (ATC A) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase III: 1 Phase II: 2 Phase I: 1

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

1 trial
  • Assistance Publique Hopitaux De Paris Academic
    SODIUM ASCORBATE
    2024-516394-78-00 1 country 2024 n=814
    Recruiting

Phase II

2 trials
  • Dompe' Farmaceutici S.p.A. Commercial
    REPARIXIN
    2024-512621-88-00 2 countries 2022 n=15
    Ended
  • Charite Universitaetsmedizin Berlin KöR Academic
    IMLIFIDASE
    2024-516727-13-00 1 country 2023 n=10
    Recruiting

Phase I

1 trial
  • Peaches Biotech S.L. Commercial
    IMP not specified
    2023-507700-32-00 1 country 2024 n=50
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Peaches Biotech S.L. Commercial 1 Phase I 1
Dompe' Farmaceutici S.p.A. Commercial 1 Phase II 0
Charite Universitaetsmedizin Berlin KöR Academic 1 Phase II 1
Assistance Publique Hopitaux De Paris Academic 1 Phase III 1
New trials by year
2022
1
2023
1
2024
2
← All indication landscapes